文献速递心境障碍

抑郁症与自杀者皮层5-HT2A受体的系统综述与荟萃分析

Cortical 5-HT2A receptors in depression and suicide: a systematic review and meta-analysis of in vivo and post-mortem imaging studies.
PubMed 文献 · Mol Psychiatry · 2025-10-06

该系统综述与荟萃分析纳入31项PET、SPECT及死后放射配体结合研究,比较556例抑郁症患者或自杀者与526名对照的皮层5-HT2A受体结合。结果显示,未服抗抑郁药的活体抑郁症患者额叶、前额叶、扣带回及颞叶皮层5-HT2A受体结合显著降低,且额叶和扣带回效应量与基线抑郁严重度相关;多数死后研究结果为阴性。

要点

  • 活体抑郁症患者额叶、扣带回、颞叶皮层5-HT2A受体结合显著降低。
  • 额叶和扣带回受体结合效应量与基线抑郁严重度相关。
  • 多数死后研究未发现5-HT2A受体结合差异,证据主要来自活体影像。

核心结论

  • 活体抑郁症患者额叶、扣带回和颞叶皮层5-HT2A受体结合降低,主要基于拮抗剂或反向激动剂放射性示踪剂研究。

研究设计与样本

  • 系统综述与荟萃分析,检索建库至2024年8/9月,纳入31项PET、SPECT及死后放射配体结合研究,共556例抑郁症患者或自杀者与526名对照。

主要发现

  • 未服抗抑郁药(停药1周至从未用药)的活体抑郁症患者额叶、前额叶、扣带回、前扣带回及颞叶皮层5-HT2A受体结合显著低于对照(Hedges' g = -0.40至-0.57)。
  • 额叶和扣带回区域结合效应量与基线抑郁严重度相关。
  • 研究水平证据显示从未用药抑郁症患者区域结合降低,探索性荟萃分析在前扣带回达显著。
  • 多数死后分析结果为阴性,纳入研究质量不一;发表偏倚证据有限。

关键数值与推荐

  • 活体抑郁症患者皮层5-HT2A受体结合降低的效应量Hedges' g范围为-0.40至-0.57。

临床怎么用

  • 活体影像提示抑郁症患者额叶、扣带回和颞叶皮层5-HT2A受体结合降低,可作为理解5-HT2A受体靶向治疗机制的参考。

局限性

  • 多数死后分析结果为阴性且纳入研究质量不一;发表偏倚证据有限;结论主要基于拮抗剂或反向激动剂放射性示踪剂研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Major depressive disorder (MDD) is a leading cause of suicide and disability. Better understanding changes to serotonin2A receptors (5-HT2ARs) in MDD and suicide may help to improve treatments. We systematically reviewed and meta-analysed positron emission tomography (PET), single photon emission computed tomography (SPECT) and post-mortem radioligand binding studies of cortical 5-HT2ARs in MDD and suicide. METHODS: Databases were searched from inception to August/September 2024. Binding data were extracted and pooled before random-effects meta-analyses of mean difference (Hedges' g) and variance were undertaken. Simple linear regression was performed to investigate the relationship between receptor binding and depression severity at baseline in PET and SPECT studies. We also assessed study quality and tested for evidence of publication bias. RESULTS: Data on 556 MDD patients or suicide victims and 526 controls from 31 studies were included. Cortical 5-HT2AR binding was significantly lower in living MDD patients, who had not taken antidepressants for between one week and forever, than controls in frontal, prefrontal, cingulate, anterior cingulate and, upon sensitivity analysis, temporal cortex (Hedges' g = -0.40 to -0.57). In frontal and cingulate regions, binding effect size correlated with depression severity at baseline. There was study-level evidence of lower regional binding in never-medicated MDD patients than controls which, upon exploratory meta-analysis, reached significance in anterior cingulate cortex. Most PET or SPECT studies were of good or fair quality. The results of most post-mortem analyses were negative and included studies were of variable quality. There was limited evidence of publication bias. CONCLUSION: In vivo 5-HT2AR binding is reduced in MDD in frontal, cingulate and temporal cortex. This finding is based mainly on studies that used antagonist or inverse agonist radiotracers.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Chapman GE, Turner G, Noar AP, et al. Cortical 5-HT2A receptors in depression and suicide: a systematic review and meta-analysis of in vivo and post-mortem imaging studies. Mol Psychiatry. 2025. PMID: 41053435. doi:10.1038/s41380-025-03233-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。